301130 西点药业
已收盘 09-18 15:00:00
资讯
新帖
简况
西点药业(301130.SZ)累计回购5.04%股份 耗资9427万元
智通财经 · 17:21
西点药业(301130.SZ)累计回购5.04%股份 耗资9427万元
西点药业(301130.SZ)累计回购近5%股份 耗资9341.89万元
智通财经 · 09-02
西点药业(301130.SZ)累计回购近5%股份 耗资9341.89万元
西点药业(301130)2024年中报简析:增收不增利
证券之星 · 08-30
西点药业(301130)2024年中报简析:增收不增利
图解西点药业中报:第二季度单季净利润同比减49.83%
证券之星 · 08-28
图解西点药业中报:第二季度单季净利润同比减49.83%
西点药业最新公告:上半年净利润同比下降19.36%
证券之星 · 08-28
西点药业最新公告:上半年净利润同比下降19.36%
西点药业(301130.SZ)发布上半年业绩,净利润2445.17万元,同比下降19.36%
智通财经 · 08-28
西点药业(301130.SZ)发布上半年业绩,净利润2445.17万元,同比下降19.36%
更名岩山股份一年后:新业务烧钱,旧业务低迷,炒股巨亏|看财报
钛媒体APP · 08-26
更名岩山股份一年后:新业务烧钱,旧业务低迷,炒股巨亏|看财报
A股猴痘概念股震荡走弱,凯普生物跌超8%,透景生命、海辰药学跌超7%,普利制药、易瑞生物、西点药业、亚太药业跟跌。
美港电讯 · 08-21
A股猴痘概念股震荡走弱,凯普生物跌超8%,透景生命、海辰药学跌超7%,普利制药、易瑞生物、西点药业、亚太药业跟跌。
A股维生素概念股震荡走低,河化股份跌停,金城医药跌超16%,西点药业、仟源医药、众生药业、新华制药等跟跌。
美港电讯 · 08-19
A股维生素概念股震荡走低,河化股份跌停,金城医药跌超16%,西点药业、仟源医药、众生药业、新华制药等跟跌。
西点药业(301130)8月16日主力资金净卖出426.87万元
证券之星 · 08-19
西点药业(301130)8月16日主力资金净卖出426.87万元
A股猴痘概念股震荡下跌,凯普生物跌超9%,西点药业、兰卫医学、达安基因跌超5%,科华生物、易瑞生物、华仁药业等跟跌。
美港电讯 · 08-16
A股猴痘概念股震荡下跌,凯普生物跌超9%,西点药业、兰卫医学、达安基因跌超5%,科华生物、易瑞生物、华仁药业等跟跌。
A股猴痘概念股开盘大涨,海辰药业、亚太药业涨停,西点药业、博晖创新涨超10%,凯普生物、优宁维、达安基因等均大幅高开。
美港电讯 · 08-15
A股猴痘概念股开盘大涨,海辰药业、亚太药业涨停,西点药业、博晖创新涨超10%,凯普生物、优宁维、达安基因等均大幅高开。
西点药业(301130)8月9日主力资金净买入264.39万元
证券之星 · 08-12
西点药业(301130)8月9日主力资金净买入264.39万元
西点药业:收到硫酸氨基葡萄糖胶囊药品注册受理通知书
中国财富通 · 08-09
西点药业:收到硫酸氨基葡萄糖胶囊药品注册受理通知书
西点药业:硫酸氨基葡萄糖胶囊注册申请获受理
中国 · 08-09
西点药业:硫酸氨基葡萄糖胶囊注册申请获受理
西点药业(301130.SZ):硫酸氨基葡萄糖胶囊药品注册上市许可获受理
智通财经 · 08-09
西点药业(301130.SZ):硫酸氨基葡萄糖胶囊药品注册上市许可获受理
西点药业(301130.SZ)已累计回购4.9953%股份 耗资约9341.9万元
智通财经 · 08-01
西点药业(301130.SZ)已累计回购4.9953%股份 耗资约9341.9万元
西点药业:公司发布的股份回购期间尚未到期,敬请关注公司后续发布的进展公告
证券之星 · 07-29
西点药业:公司发布的股份回购期间尚未到期,敬请关注公司后续发布的进展公告
西点药业最新公告:参加联盟组织药品集中带量采购续签药品中选
证券之星 · 07-12
西点药业最新公告:参加联盟组织药品集中带量采购续签药品中选
西点药业公告,公司于近日参加省级联盟组织的药品集中带量采购的续签工作。截至公告披露日,公司生产的草酸艾司西酞普兰片已陆续中选《广东联盟阿莫西林等药品集中带量采购》《2024年河北省国家集采第一、二、四批药品到期续签采购项目》。
华尔街见闻 · 07-12
西点药业公告,公司于近日参加省级联盟组织的药品集中带量采购的续签工作。截至公告披露日,公司生产的草酸艾司西酞普兰片已陆续中选《广东联盟阿莫西林等药品集中带量采购》《2024年河北省国家集采第一、二、四批药品到期续签采购项目》。
加载更多
公司概况
公司名称:
吉林省西点药业科技发展股份有限公司
所属行业:
医药制造业
上市日期:
2022-02-23
主营业务:
吉林省西点药业科技发展股份有限公司主营业务是化学药品原料药及制剂的研发、生产、销售。公司主要产品为复方硫酸亚铁叶酸片、利培酮口崩片、草酸艾司西酞普兰片、瑞香素胶囊、阿魏酸钠、阿魏酸钠、阿魏酸钠、阿魏酸钠。公司荣获“国家火炬计划重点高新技术企业”、等称号。
发行价格:
22.55
{"stockData":{"symbol":"301130","market":"SZ","secType":"STK","nameCN":"西点药业","latestPrice":22.7,"timestamp":1726643022000,"preClose":23.36,"halted":0,"volume":843100,"delay":0,"floatShares":58028100,"shares":80803900,"eps":0.5524,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.66,"latestTime":"09-18 15:00:00","open":23.36,"high":23.54,"low":22.56,"amount":19290000,"amplitude":0.042,"askPrice":22.72,"askSize":44,"bidPrice":22.68,"bidSize":32,"shortable":0,"etf":0,"ttmEps":0.5524,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726709400000},"adr":0,"adjPreClose":23.36,"symbolType":"stock","openAndCloseTimeList":[[1726623000000,1726630200000],[1726635600000,1726642800000]],"highLimit":25.7,"lowLimit":21.02,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":80803943,"pbRate":2.11,"roa":"--","roe":"2.56%","epsLYR":0.625,"committee":0.24424,"marketValue":1834000000,"floatMarketCap":1317000000,"peRate":41.093411,"changeRate":-0.0283,"turnoverRate":0.0145,"status":1},"requestUrl":"/m/hq/s/301130","defaultTab":"news","newsList":[{"id":"2468082123","title":"西点药业(301130.SZ)累计回购5.04%股份 耗资9427万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468082123","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468082123?lang=zh_cn&edition=full","pubTime":"2024-09-18 17:21","pubTimestamp":1726651274,"startTime":"0","endTime":"0","summary":"智通财经APP讯,西点药业(301130.SZ)公告,截至2024年9月18日,公司累计回购股份407.40万股,占公司目前总股本的5.0418%,最高成交价为26.22元/股,最低成交价为20.65元/股,成交总金额为9427.04万元(不含交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301130","BK0239"],"gpt_icon":0},{"id":"2464868168","title":"西点药业(301130.SZ)累计回购近5%股份 耗资9341.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2464868168","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464868168?lang=zh_cn&edition=full","pubTime":"2024-09-02 17:08","pubTimestamp":1725268094,"startTime":"0","endTime":"0","summary":"智通财经APP讯,西点药业(301130.SZ)公告,截至2024年8月30日,公司累计以集中竞价交易方式回购公司股份403.65万股,占公司目前总股本的4.9953%,成交总金额为9341.89万元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2463147642","title":"西点药业(301130)2024年中报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2463147642","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463147642?lang=zh_cn&edition=full","pubTime":"2024-08-30 06:29","pubTimestamp":1724970561,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期西点药业发布2024年中报。根据财报显示,西点药业增收不增利。截至本报告期末,公司营业总收入1.29亿元,同比上升13.04%,归母净利润2445.17万元,同比下降19.36%。按单季度数据看,第二季度营业总收入6226.37万元,同比上升6.17%,第二季度归母净利润1040.89万元,同比下降49.83%。本次财报公布的各项数据指标表现一般。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000006907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"gpt_icon":0},{"id":"2462439304","title":"图解西点药业中报:第二季度单季净利润同比减49.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462439304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462439304?lang=zh_cn&edition=full","pubTime":"2024-08-28 17:18","pubTimestamp":1724836714,"startTime":"0","endTime":"0","summary":"证券之星消息,西点药业2024年中报显示,公司主营收入1.29亿元,同比上升13.04%;归母净利润2445.17万元,同比下降19.36%;扣非净利润2083.14万元,同比上升39.1%;其中2024年第二季度,公司单季度主营收入6226.37万元,同比上升6.17%;单季度归母净利润1040.89万元,同比下降49.83%;单季度扣非净利润877.03万元,同比上升1.56%;负债率7.48%,投资收益144.89万元,财务费用-189.85万元,毛利率78.4%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800032817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130"],"gpt_icon":0},{"id":"2462268480","title":"西点药业最新公告:上半年净利润同比下降19.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462268480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462268480?lang=zh_cn&edition=full","pubTime":"2024-08-28 16:28","pubTimestamp":1724833701,"startTime":"0","endTime":"0","summary":"西点药业发布2024年半年度报告,报告期内,营业收入1.29亿元,同比增长13.04%;归属于母公司所有者的净利润2445.17万元,同比减少19.36%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800029488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130"],"gpt_icon":0},{"id":"2462348212","title":"西点药业(301130.SZ)发布上半年业绩,净利润2445.17万元,同比下降19.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462348212","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462348212?lang=zh_cn&edition=full","pubTime":"2024-08-28 15:56","pubTimestamp":1724831771,"startTime":"0","endTime":"0","summary":"智通财经APP讯,西点药业(301130.SZ)发布2024年半年度报告,公司营业收入1.29亿元,同比增长13.04%;归属于上市公司股东的净利润2445.17万元,同比下降19.36%;归属于上市公司股东的扣除非经常性损益的净利润2083.14万元,同比增长39.10%;基本每股收益0.3026元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1172987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301130"],"gpt_icon":0},{"id":"2462952853","title":"更名岩山股份一年后:新业务烧钱,旧业务低迷,炒股巨亏|看财报","url":"https://stock-news.laohu8.com/highlight/detail?id=2462952853","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462952853?lang=zh_cn&edition=full","pubTime":"2024-08-26 15:36","pubTimestamp":1724657760,"startTime":"0","endTime":"0","summary":"今年上半年,岩山科技的互联网信息业务营收为2.29亿元,同比减少6.8%,在整体业务中占比67.53%。去年8月31日,岩山科技公告称全资子公司瑞丰智能拟增资并收购Nullmax部分股权,其中以6.75亿元增资,溢价超过18倍,以3.21亿元收购部分股权,溢价也超过17倍。近年来,岩山科技被外界戏称为理财大师,公司沉迷理财投资一直为人诟病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/cj/2024-08-26/doc-inckyeri4910618.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2024-08-26/doc-inckyeri4910618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0183","BK0196","BK0231","BK0154","BK0239","002173","BK0114","301130","BK0077","BK0236","BK0095","002195","BK0096"],"gpt_icon":0},{"id":"2461631788","title":"A股猴痘概念股震荡走弱,凯普生物跌超8%,透景生命、海辰药学跌超7%,普利制药、易瑞生物、西点药业、亚太药业跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2461631788","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461631788?lang=zh_cn&edition=full","pubTime":"2024-08-21 09:47","pubTimestamp":1724204832,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300942","002370","300630","300639","BK0046","300642","399300","BK0239","BK0132","301130","159982","BK0042"],"gpt_icon":0},{"id":"2460724895","title":"A股维生素概念股震荡走低,河化股份跌停,金城医药跌超16%,西点药业、仟源医药、众生药业、新华制药等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2460724895","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460724895?lang=zh_cn&edition=full","pubTime":"2024-08-19 09:47","pubTimestamp":1724032053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0066","BK0010","BK0077","BK0046","301130","BK0042","BK0004","BK0071","159982","BK0188","BK0239","002317","399300","300233","000953","000756","300254","BK0028","BK0114","BK0164"],"gpt_icon":0},{"id":"2460267407","title":"西点药业(301130)8月16日主力资金净卖出426.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460267407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460267407?lang=zh_cn&edition=full","pubTime":"2024-08-19 09:11","pubTimestamp":1724029877,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月16日收盘,西点药业报收于28.45元,上涨8.8%,换手率11.4%,成交量6.61万手,成交额1.77亿元。近5日资金流向一览见下表:西点药业融资融券信息显示,融资方面,当日融资买入1200.25万元,融资偿还1156.86万元,融资净买入43.39万元。西点药业主营业务:化学药品原料药及制剂研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081900002316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"gpt_icon":0},{"id":"2459394562","title":"A股猴痘概念股震荡下跌,凯普生物跌超9%,西点药业、兰卫医学、达安基因跌超5%,科华生物、易瑞生物、华仁药业等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2459394562","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459394562?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:45","pubTimestamp":1723772727,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0159","002022","BK0122","BK0102","301060","159982","BK0046","002030","399300","BK0042","301130","BK0236","BK0028","BK0132","BK0168","BK0239","300942","300110","BK0188","300639"],"gpt_icon":0},{"id":"2459045717","title":"A股猴痘概念股开盘大涨,海辰药业、亚太药业涨停,西点药业、博晖创新涨超10%,凯普生物、优宁维、达安基因等均大幅高开。","url":"https://stock-news.laohu8.com/highlight/detail?id=2459045717","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459045717?lang=zh_cn&edition=full","pubTime":"2024-08-15 09:28","pubTimestamp":1723685304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0132","BK0168","BK0250","300318","301166","BK0251","BK0046","002370","BK0122","301130","BK0042","159982","300584","BK0188","BK0239","399300","300639","BK0048","BK0028","002030","BK0159"],"gpt_icon":0},{"id":"2458648185","title":"西点药业(301130)8月9日主力资金净买入264.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458648185","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458648185?lang=zh_cn&edition=full","pubTime":"2024-08-12 09:11","pubTimestamp":1723425110,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月9日收盘,西点药业报收于25.76元,上涨3.87%,换手率5.48%,成交量3.18万手,成交额7804.41万元。近5日资金流向一览见下表:西点药业融资融券信息显示,融资方面,当日融资买入443.72万元,融资偿还380.51万元,融资净买入63.21万元。西点药业主营业务:化学药品原料药及制剂研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200002366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"gpt_icon":0},{"id":"2458953417","title":"西点药业:收到硫酸氨基葡萄糖胶囊药品注册受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2458953417","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458953417?lang=zh_cn&edition=full","pubTime":"2024-08-09 15:19","pubTimestamp":1723187974,"startTime":"0","endTime":"0","summary":"中国财富通8月9日 - 西点药业(301130)公告称,公司于近日收到国家药品监督管理局签发的硫酸氨基葡萄糖胶囊境内生产药品注册上市许可《受理通知书》,国家药监局经审查,决定予以受理。根据相关法规规定,上述药品已获得注册申请受理,报送国家药监局药品审评中心进行审评审批。上述药品获得受理通知书对公司近期业绩不会产生影响,相关药品的注册批件取得时间和结果均具有不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=5wRUYLdhSpc%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301130","BK0239"],"gpt_icon":0},{"id":"2458535890","title":"西点药业:硫酸氨基葡萄糖胶囊注册申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2458535890","media":"中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458535890?lang=zh_cn&edition=full","pubTime":"2024-08-09 13:02","pubTimestamp":1723179720,"startTime":"0","endTime":"0","summary":"中证智能财讯西点药业8月9日午间公告,公司近日收到国家药监局签发的硫酸氨基葡萄糖胶囊境内生产药品注册上市许可《受理通知书》。硫酸氨基葡萄糖胶囊用于原发性或继发性骨关节炎。截至公告披露之日,已获得硫酸氨基葡萄糖胶囊注册批件的国内药品生产企业为12家。2024年第一季度,公司实现营业总收入6670.55万元,同比增长20.32%;净利润1404.28万元,同比增长46.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-08-09/doc-inchzpnf7560983.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-08-09/doc-inchzpnf7560983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2458589273","title":"西点药业(301130.SZ):硫酸氨基葡萄糖胶囊药品注册上市许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2458589273","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458589273?lang=zh_cn&edition=full","pubTime":"2024-08-09 11:57","pubTimestamp":1723175839,"startTime":"0","endTime":"0","summary":"智通财经APP讯,西点药业(301130.SZ)发布公告,公司于近日收到国家药品监督管理局(“国家药监局”)签发的硫酸氨基葡萄糖胶囊境内生产药品注册上市许可《受理通知书》,国家药监局根据《中华人民共和国行政许可法》第三十二条的规定,经审查,决定予以受理。据悉,硫酸氨基葡萄糖胶囊,用于原发性或继发性骨关节炎。经查询国家药监局网站,截至本公告披露之日,已获得硫酸氨基葡萄糖胶囊注册批件的国内药品生产企业为12家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1162069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301130","BK0239"],"gpt_icon":0},{"id":"2456797771","title":"西点药业(301130.SZ)已累计回购4.9953%股份 耗资约9341.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456797771","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456797771?lang=zh_cn&edition=full","pubTime":"2024-08-01 16:02","pubTimestamp":1722499361,"startTime":"0","endTime":"0","summary":"智通财经APP讯,西点药业(301130.SZ)发布公告,截至2024年7月31日,公司累计通过回购专用证券账户以集中竞价交易方式回购公司股份403.65万股,占公司目前总股本的4.9953%,最高成交价为26.22元/股,最低成交价为20.65元/股,成交总金额为9341.9万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1158646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2455395246","title":"西点药业:公司发布的股份回购期间尚未到期,敬请关注公司后续发布的进展公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2455395246","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455395246?lang=zh_cn&edition=full","pubTime":"2024-07-29 17:04","pubTimestamp":1722243858,"startTime":"0","endTime":"0","summary":"证券之星消息,西点药业(301130)07月29日在投资者关系平台上答复投资者关心的问题。投资者:请问公司回购的股份什么时候注销,西点药业董秘:尊敬的投资者,您好!公司发布的股份回购期间尚未到期,敬请关注公司后续发布的进展公告。谢谢!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072900025588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301130","BK0239"],"gpt_icon":0},{"id":"2450330361","title":"西点药业最新公告:参加联盟组织药品集中带量采购续签药品中选","url":"https://stock-news.laohu8.com/highlight/detail?id=2450330361","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450330361?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:28","pubTimestamp":1720772918,"startTime":"0","endTime":"0","summary":"西点药业公告,公司于近日参加省级联盟组织的药品集中带量采购的续签工作。截至公告披露日,公司生产的草酸艾司西酞普兰片已陆续中选《广东联盟阿莫西林等药品集中带量采购》《2024年河北省国家集采第一、二、四批药品到期续签采购项目》。草酸艾司西酞普兰片,是用于治疗抑郁症,治疗伴有或不伴有广场恐惧症的惊恐障碍的药品。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200031557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301130"],"gpt_icon":0},{"id":"2450388370","title":"西点药业公告,公司于近日参加省级联盟组织的药品集中带量采购的续签工作。截至公告披露日,公司生产的草酸艾司西酞普兰片已陆续中选《广东联盟阿莫西林等药品集中带量采购》《2024年河北省国家集采第一、二、四批药品到期续签采购项目》。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450388370","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450388370?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:07","pubTimestamp":1720771646,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK0239","301130"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-02-23","address":"吉林省吉林市磐石市磐石经济开发区西点大街777号","stockEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0723},{"period":"3month","weight":-0.0234},{"period":"6month","weight":0.0268},{"period":"1year","weight":-0.234},{"period":"ytd","weight":-0.1529}],"companyName":"吉林省西点药业科技发展股份有限公司","boardCode":"AI0027","perCapita":"8213股","boardName":"医药制造业","registeredCapital":"8080万元","compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0514},{"period":"3month","weight":-0.1083},{"period":"6month","weight":-0.1148},{"period":"1year","weight":-0.1351},{"period":"ytd","weight":-0.091}],"survey":" 吉林省西点药业科技发展股份有限公司主营业务是化学药品原料药及制剂的研发、生产、销售。公司主要产品为复方硫酸亚铁叶酸片、利培酮口崩片、草酸艾司西酞普兰片、瑞香素胶囊、阿魏酸钠、阿魏酸钠、阿魏酸钠、阿魏酸钠。公司荣获“国家火炬计划重点高新技术企业”、等称号。","serverTime":1726670646193,"listedPrice":22.55,"stockholders":"7065人(较上一季度减少13.79%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"西点药业(301130)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供西点药业(301130)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"西点药业,301130,西点药业股票,西点药业股票老虎,西点药业股票老虎国际,西点药业行情,西点药业股票行情,西点药业股价,西点药业股市,西点药业股票价格,西点药业股票交易,西点药业股票购买,西点药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"西点药业(301130)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供西点药业(301130)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}